دسته: ایمونو هیستوشیمی
نمایش 441–460 از 540 نتیجه
فیلتر ها-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Cytokeratin 20 کلون E19-1 برند Patho Sage
نمره 0 از 5Specification:
Keratin 20 / cytokeratin20 (CK20) is a type-I keratin which is primarily expressed in gastric and intestinal epithelium, urothelium, and Merkel-cells. CK20 is expressed in adenocarcinomas of the colon, stomach, pancreas and the bile system. CK20 is also present in mucinous ovarian tumours, transitional-cell and Merkel-cell carcinomas.
Immunogen:
Peptide derived from C-terminal region of human cytokeratin 20
Presentation:
monospecific rabbit clonal antibody in 20 mM Tris-HCl, pH 8.0 with 20 mg/ml BSA and 0.05% NaN3
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی EMA (Epithelial Membrane Antigen /MUC-1) کلون E29 برند Patho Sage
نمره 0 از 5Specification:
Anti-EMA antibody is a useful marker for staining many carcinomas. It stains normal and neoplastic cells from various tissues, including mammary epithelium, sweat glands and squamous epithelium. Hepatocellular carcinoma, adrenal carcinoma and embryonal carcinomas are consistently EMA negative, so keratin positivity with negative EMA favors one of these tumors. EMA is frequently positive in meningioma, which can be useful when distinguishing it from other intracranial neoplasms, e.g. Schwannomas. The absence of EMA can also be of value since negative EMA staining is characteristic of some tumors including adrenal carcinoma, seminomas, paraganglioma and hepatoma.
Immunogen:
Delipidated extract of human milk fat globule membranes
Presentation:
Bioreactor Concentrate with 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی CD2 کلون EP222 برند Patho Sage
نمره 0 از 5Specification:
CD2 is one of the earliest T-cell lineage restricted antigens to appear during T-cell differentiation and only rare CD2+ cells can be found in the bone marrow. Anti-CD2 is a pan-T-cell antigen marker. Anti-CD2 is therefore useful for the identification of virtually all normal T-lymphocytes. It is also very useful in the assessment of lymphoid malignancies as it is expressed in the majority of precursor and mature T-cell lymphomas and leukemias. As with other pan-T-cell antigens, CD2 may be aberrantly deleted in some neoplastic T-cell populations, especially peripheral T-cell lymphomas. When combined with antiCD25, antiCD2 may assist in the identification of systemic macrocytosis and mastocyte leukemia.
Immunogen:
A human CD2 recombinant protein
Presentation:
Antibody in Phosphate Buffered Saline, pH 7.2, with 1% BSA and <0.1% Sodium Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی CD21 کلون EP3093 برند Patho Sage
نمره 0 از 5Specification:
CD21 antigen is an integral membrane glycoprotein of molecular weight 140 kD. Anti-CD21 is useful in the identification of follicular dendritic cell matrix found in normal lymph nodes and tonsillar tissue. This antibody also labels follicular dendritic cell tumor/sarcomas. The antigen is absent on T-lymphocytes, monocytes, and granulocytes. Associated products: CD35, Follicular Dendritic Cell
Presentation:
Anti-CD21 is a rabbit monoclonal from tissue culture supernatant diluted in tris buffered saline, pH 7.3-7.7, with protein base, and preserved with sodium azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی P16-INK4 کلون G175-405 برند Patho Sage
نمره 0 از 5Specification:
Cyclins and cyclin-dependent kinases (cdks) form active complexes that regulate key events during the progression of the cell cycle and are evolutionarily highly conserved. The p16 protein has been identified as a specific inhibitor of cdk4 because it blocks cdk4 substrate phosphorylation. p16 inhibits cdk4 dependent phosphorylation of the tumor suppressor retinoblastoma protein (Rb) and Rb related proteins, p107 and p130. The biochemical properties of p16 suggest that it may be a tumor suppressor gene product. Recently a gene cloned from the short arm of human chromosome 9, Multiple Tumor Suppressor 1 (MTS1) has been identified as the gene for p16. The gene, now also known as the CDKN2 gene, has been found to be mutated in a very high percentage of tumors, including 75% of melanoma cell lines.
Presentation:
Monoclonal antibody purified from tissue culture supernatant or ascites by affinity chromatography. Aqueous buffered solution containing BSA, goat serum, and ≤0.09% sodium azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی EMA (Epithelial Membrane Antigen /MUC-1) کلون GP1.4 برند Patho Sage
نمره 0 از 5Specification:
In Western blotting, anti-EMA (MUC-1) recognizes proteins in MW range of 265-400kDa, identified as different glycoforms of EMA. This MAb reacts with the DTRP epitope in the tandem repeats. The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. EMA may provide a protective layer on epithelial cells against bacterial and enzyme attack. The beta subunit contains a C-terminal domain, which is involved in cell signaling, through phosphorylation’s and protein-protein interactions. In immunohistochemical assays, it superbly stains routine formalin/paraffin carcinoma tissues. Antibody to EMA is useful as a pan-epithelial marker for detecting early metastatic loci of carcinoma in bone marrow or liver.
Immunogen:
Human milk fat globule membranes
Presentation:
Bioreactor Concentrate with 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Caldesmon کلون H-Cald برند Patho Sage
نمره 0 از 5Specification:
Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120–150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70–80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.
Immunogen:
Crude human uterus extract
Presentation:
Bioreactor Concentrate with 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی CD79a (MB-1) کلون JCB117 برند Patho Sage
نمره 0 از 5Specification:
A disulphide-linked heterodimer, consisting of mb-1 (or CD79a) and B29 (or CD79b) polypeptides, is non-covalently associated with membrane-bound immunoglobulins on B cells. This complex of mb-1 and B29 polypeptides and immunoglobulin constitute the B cell Ag receptor. CD79a first appears at pre B cell stage, early in maturation, and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in the majority of acute leukemias of precursor B cell type, in B cell lines, B cell lymphomas, and in some myelomas. It is not present in myeloid or T cell lines. It is superb for staining formalin-fixed, paraffin-embedded B-cell lymphomas.
Immunogen:
A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein
Presentation:
Bioreactor Concentrate with 0.05% Azide.
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Cytokeratin 5 کلون KRT5/3594 برند Patho Sage
نمره 0 از 5Specification:
This Mab recognizes a protein of 58kDa, which is identified as Cytokeratin 5 (KRT5). This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Antibodies to KRT5 identify basal cells of squamous and glandular epithelia, myoepithelial and mesothelium. Anti-Cytokeratin 5 has been reported useful in the differential diagnosis of metastatic carcinoma in the pleura versus epithelioid mesothelioma. Almost all squamous cell carcinomas, half of transitional carcinomas and many undifferentiated large cell carcinomas express. Anti-KRT5, along with anti-p63, affords a high sensitivity and specificity for squamous differentiation. Myoepithelial cells of the breast, glandular epithelia and basal cells of the prostate are labeled with anti-KRT5.
Immunogen:
Recombinant fragment (around aa316-590) of human Cytokeratin 5 (KRT5) protein (exact sequence is proprietary)
Presentation:
Bioreactor Concentrate with 0.05% BSA and 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Lambda Immunoglobulin Light Chain کلون LCN-2 برند Patho Sage
نمره 0 از 5Specification:
This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin’s lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant.
Immunogen:
Purified human IgG myeloma proteins coupled to polyaminostyren microbeads
Presentation:
Bioreactor Concentrate with 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی MBP (Myelin Basic Protein) کلون MBP/4277R برند Patho Sage
نمره 0 از 5Specification:
Myelin basic protein (MBP) is the second most abundant protein in central nervous system (CNS) myelin; it comprises 30% of the total protein and about 10% of the dry weight of myelin. It is the only structural protein found so far to be essential for formation of CNS myelin, and has been called the ‘’executive molecule of myelin’. MBP can interact with a number of polyanionic proteins including actin, tubulin, calmodulin and clathrin and negatively charged lipids, and acquires structure on binding to them. It may acts as a membrane actin-binding protein, which might allow it to participate in transmission of extracellular signals to the cytoskeleton in oligodendrocyte and tight junctions in myelin. MBP may be applicable as a marker for oligodendrogliomas
Immunogen:
Recombinant fragment (around aa 150-250) of human MBP (Exact sequence is proprietary)
Presentation:
Bioreactor Concentrate with 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Napsin A کلون MX0165 برند Patho Sage
نمره 0 از 5Specification:
Napsin A is an aspartic protease with a molecular weight of approximately 38 kDa, expressed in type-II pneumocytes and is involved in the N- and C-terminal processing of proSP-B in type-II pneumocytes. TAO2 has been shown to be identical with Napsin A. There is also a Napsin B gene which is transcribed exclusively in cells related to the immune system but lacks a stop codon and may represent a transcribed pseudogene. Napsin A is predominantly expressed in the lung and kidney. In the lung, Napsin A is expressed in alveolar type II pneumocytes, regulated by TTF-1, and is involved in the generation of the surfactant protein B. Intra-alveolar macrophages contain Napsin A as a result of phagocytosis. In the kidney, Napsin A is expressed in the proximal tubules, where it is involved in lysosomal protein catabolism.
Presentation:
Liquid tissue culture supernatant containing 15mM sodium azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Cadherin E کلون MX020 برند Patho Sage
نمره 0 از 5Specification:
ECAD (syn, CD325), 120 kDA, chromosome 16q22.1 (CDH1 gene), is a critical regulator of epithelial junction formation. It interacts with the cytoskeleton through several associated proteins. The ECAD internal domain binds with alpha, beta, gamma and p120 catenin’s to anchor the ECAD complex to the actin cytoskeleton of the cell. ECAD is expressed in virtually all epithelial cells except for adrenocortical cells. The expression in liver cells is weaker than in most other epithelia. ECAD is also expressed in melanocytes (adhering to squamous epithelial cells).
Presentation:
Tissue culture supernatant containing 15mM sodium azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Cytokeratin 18 کلون MX035 برند Patho Sage
نمره 0 از 5Specification:
Cytokeratin’s (epithelial keratins) are an important component of the intermediate filament system. They are mainly insoluble molecules playing an important role in cellular mechanics. There are two types of cytokeratin’s: a) type I: (9-20) keratins that are relatively acidic and bearing a small molecular weight (40-56.5 kDa) and b) type II: (1-8) that are relatively basic-neutral of larger molecular weight (53-67 kDa). Proliferating cells have a substantial pool of two soluble cytokeratin’s, namely CK8 and CK18 and their concentration is high during the G2-M phase of the cell cycle. During apoptosis, CK18 are cleaved by caspases at position Asp396 producing relatively stable fragments.
Presentation:
Tissue culture supernatant containing 15mM sodium azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی CD56 (NCAM-1) کلون MX039 برند Patho Sage
نمره 0 از 5Specification:
CD56, also known as neural cell adhesion molecule (NCAM). CD56 mediates cell-cell and cell-matrix interaction via homophilic binding and heterophilic binding to heparin/heparin sulphate and collagens. CD56 occurs widely in the central nervous system (neurons and glia cells but not choroid plexus), peripheral nerves and skeletal muscles, most types of neuroendocrine cells and various epithelia (enterocytes and newly formed bile ductular cells), ovarian stromal cells, uterine smooth muscle cells and osteoblasts. In the hematopoietic system, CD56 is the prototypic marker of NK cells, but also present on subsets of CD4+ and CD8+ T-cells.
Presentation:
Tissue culture supernatant containing 15mM sodium azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Napsin A کلون NAPSA/1239 برند Patho Sage
نمره 0 از 5Specification:
Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B. There are two closely related Napsin, Napsin A and Napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of Napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of Napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.
Immunogen:
Recombinant fragment of human Napsin A protein
Presentation:
Antibody in Bioreactor Concentrate with 0.05% BSA and 0.05% Azide.
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی CD57 کلون NK-1 برند Patho Sage
نمره 0 از 5Specification:
NK-1 antibody marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. NK-1 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor, and medulloblastoma. NK-1 reportedly also reacts with a variety of cell types in non-lymphoid tissues, including neurofibroma, ganglioneuroma, and prostate carcinoma.
Immunogen:
Human peripheral blood mononuclear cells
Presentation:
Bioreactor Concentrate with 0.05% Azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی MDM2 کلون SMP14 برند Patho Sage
نمره 0 از 5Specification:
MDM2, originally described as a gene product of mouse double minute chromosomes, is a nuclear oncoprotein that can inhibit the action of certain tumor suppressor proteins. For example, MDM2 binds to the acidic activation domain (residues 2042) of the p53 tumor suppressor protein, and the p53-MDM2 complex down regulates the transcriptional activity of p53. p53 plays a role in the normal cell cycle by activating the transcription of genes that cause arrest in G1. The expression of MDM2 is itself, induced by p53 and may be a way for p53 to self-regulate its activity during the normal cell cycle. However, overexpression of MDM2 results in the loss of p53-regulated growth control and consequently, deregulated cell proliferation. MDM2 also binds to the Retinoblastoma tumor suppressor protein (Rb) and inhibits its growth regulatory function. MDM2 can directly augment proliferation by binding to two transcription factors E2F1 and DP1 and stimulating the activity of the S-phase inducing E2F1/DP1 heterodimer. MDM2 migrates at a reduced molecular weight of ~95 kDa. The SMP14 clone has been reported to recognize human, mouse and rat MDM2 while exhibiting a slight cross-reactivity with cytokeratin’s 6, 14 and 16 in some experimental systems. In the immunoprecipitation application, SMP14 has been reported to precipitate MDM2 and p53-MDM2 complexes. MCF7 human breast carcinoma cells (ATCC HTB-22) and NIH/3T3 mouse fibroblasts (ATCC CRL-1658) are suggested as western blot and immunoprecipitation positive controls. SMP14 has been reported to be useful for the immunohistochemical staining of acetone-fixed, frozen sections and of formalin-fixed, paraffin-embedded tissue sections. In addition to a nuclear staining of MDM2, cytoplasmic staining may also be observed which is likely to be attributable to the slight cross reactivity of the SMP14 clone with cytokeratin’s.
Immunogen:
Human MDM2 aa. 154-167
Presentation:
Affinity purified antibody in aqueous buffered solution containing ≤0.09% sodium azide.
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی Tenascin C کلون T2H5 برند Patho Sage
نمره 0 از 5Specification:
Tenascin C is a multifunctional, disulfide-linkedhexameric extracellular matrix glycoprotein expressed in association with mesenchymal epithelial interactions during development and in the neo-vasculature and stroma of undifferentiated tumors. In adults, it is restricted to certain epithelial-stromal interfaces and increases markedly in hyper-proliferative diseases and in stroma of many neoplasms, including gliomas, breast, squamous and lung carcinomas.
Immunogen:
Human breast carcinoma
Presentation:
Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide
-
آنتی بادیهای ایمونوهیستوشیمی
آنتی بادی P63 کلون TP63/11 برند Patho Sage
نمره 0 از 5Specification:
p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratin’s and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts.
Immunogen:
Recombinant human p63 protein
Presentation:
Bioreactor Concentrate with 0.05% Azide